FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2952740406> ?p ?o ?g. }

• W2952740406 endingPage "103062" @default.
• W2952740406 startingPage "103062" @default.
• W2952740406 abstract "Alkaloids have always been a great source of cholinesterase inhibitors. Numerous studies have shown that inhibiting acetylcholinesterase as well as butyrylcholinetserase is advantageous, and have better chances of success in preclinical/ clinical settings. With the objective to discover dual cholinesterase inhibitors, herein we report synthesis and biological evaluation of indoloquinoline alkaloid cryptolepine (1) and its bromo-derivative 2. Our study has shown that cryptolepine (1) and its 2-bromo-derivative 2 are dual inhibitors of acetylcholinesterase and butyrylcholinesterase, the enzymes which are involved in blocking the process of neurotransmission. Cryptolepine inhibits Electrophorus electricus acetylcholinesterase, recombinant human acetylcholinesterase and equine serum butyrylcholinesterase with IC50 values of 267, 485 and 699 nM, respectively. The 2-bromo-derivative of cryptolepine also showed inhibition of these enzymes, with IC50 values of 415, 868 and 770 nM, respectively. The kinetic studies revealed that cryptolepine inhibits human acetylcholinesterase in a non-competitive manner, with ki value of 0.88 µM. Additionally, these alkaloids were also tested against two other important pathological events of Alzheimer’s disease viz. stopping the formation of toxic amyloid-β oligomers (via inhibition of BACE-1), and increasing the amyloid-β clearance (via P-gp induction). Cryptolepine displayed potent P-gp induction activity at 100 nM, in P-gp overexpressing adenocarcinoma LS-180 cells and excellent toxicity window in LS-180 as well as in human neuroblastoma SH-SY5Y cell line. The molecular modeling studies with AChE and BChE have shown that both alkaloids were tightly packed inside the active site gorge (site 1) via multiple π-π and cation-π interactions. Both inhibitors have shown interaction with the allosteric “peripheral anionic site” via hydrophobic interactions. The ADME properties including the BBB permeability were computed for these alkaloids, and were found within the acceptable range." @default.
• W2952740406 created "2019-06-27" @default.
• W2952740406 creator A5010814149 @default.
• W2952740406 creator A5014452799 @default.
• W2952740406 creator A5024494535 @default.
• W2952740406 creator A5052847815 @default.
• W2952740406 creator A5057664448 @default.
• W2952740406 date "2019-09-01" @default.
• W2952740406 modified "2023-09-26" @default.
• W2952740406 title "Synthesis and biological evaluation of indoloquinoline alkaloid cryptolepine and its bromo-derivative as dual cholinesterase inhibitors" @default.
• W2952740406 cites W1602284078 @default.
• W2952740406 cites W170237590 @default.
• W2952740406 cites W1900715746 @default.
• W2952740406 cites W1971048984 @default.
• W2952740406 cites W1973591193 @default.
• W2952740406 cites W1980790254 @default.
• W2952740406 cites W1982462327 @default.
• W2952740406 cites W2001148507 @default.
• W2952740406 cites W2003061656 @default.
• W2952740406 cites W2006152123 @default.
• W2952740406 cites W2011419101 @default.
• W2952740406 cites W2016942595 @default.
• W2952740406 cites W2019389576 @default.
• W2952740406 cites W2026641599 @default.
• W2952740406 cites W2028940007 @default.
• W2952740406 cites W2044565224 @default.
• W2952740406 cites W2047420624 @default.
• W2952740406 cites W2049319069 @default.
• W2952740406 cites W2052613003 @default.
• W2952740406 cites W2057382300 @default.
• W2952740406 cites W2074801879 @default.
• W2952740406 cites W2076166567 @default.
• W2952740406 cites W2076365092 @default.
• W2952740406 cites W2096410114 @default.
• W2952740406 cites W2101609688 @default.
• W2952740406 cites W2112006614 @default.
• W2952740406 cites W2114682709 @default.
• W2952740406 cites W2121786665 @default.
• W2952740406 cites W2122429894 @default.
• W2952740406 cites W2129590861 @default.
• W2952740406 cites W2136334732 @default.
• W2952740406 cites W2146322356 @default.
• W2952740406 cites W2147045000 @default.
• W2952740406 cites W2158603760 @default.
• W2952740406 cites W2170411477 @default.
• W2952740406 cites W2214346462 @default.
• W2952740406 cites W2300070246 @default.
• W2952740406 cites W2315120195 @default.
• W2952740406 cites W2463644552 @default.
• W2952740406 cites W2559203598 @default.
• W2952740406 cites W2560415430 @default.
• W2952740406 cites W2597990638 @default.
• W2952740406 cites W2610775815 @default.
• W2952740406 cites W2774623109 @default.
• W2952740406 cites W2790172423 @default.
• W2952740406 cites W2790798430 @default.
• W2952740406 cites W2793164549 @default.
• W2952740406 cites W2803695929 @default.
• W2952740406 cites W2805725390 @default.
• W2952740406 cites W2885235170 @default.
• W2952740406 cites W2898430716 @default.
• W2952740406 cites W2898939772 @default.
• W2952740406 cites W2901885823 @default.
• W2952740406 cites W2903095195 @default.
• W2952740406 cites W2904839245 @default.
• W2952740406 cites W2905303571 @default.
• W2952740406 cites W2906081536 @default.
• W2952740406 cites W2908415659 @default.
• W2952740406 cites W2942857870 @default.
• W2952740406 cites W990891810 @default.
• W2952740406 doi "https://doi.org/10.1016/j.bioorg.2019.103062" @default.
• W2952740406 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31220673" @default.
• W2952740406 hasPublicationYear "2019" @default.
• W2952740406 type Work @default.
• W2952740406 sameAs 2952740406 @default.
• W2952740406 citedByCount "28" @default.
• W2952740406 countsByYear W29527404062020 @default.
• W2952740406 countsByYear W29527404062021 @default.
• W2952740406 countsByYear W29527404062022 @default.
• W2952740406 countsByYear W29527404062023 @default.
• W2952740406 crossrefType "journal-article" @default.
• W2952740406 hasAuthorship W2952740406A5010814149 @default.
• W2952740406 hasAuthorship W2952740406A5014452799 @default.
• W2952740406 hasAuthorship W2952740406A5024494535 @default.
• W2952740406 hasAuthorship W2952740406A5052847815 @default.
• W2952740406 hasAuthorship W2952740406A5057664448 @default.
• W2952740406 hasConcept C181199279 @default.
• W2952740406 hasConcept C185592680 @default.
• W2952740406 hasConcept C202751555 @default.
• W2952740406 hasConcept C2777667214 @default.
• W2952740406 hasConcept C2777752497 @default.
• W2952740406 hasConcept C2778816929 @default.
• W2952740406 hasConcept C2779059548 @default.
• W2952740406 hasConcept C2779101902 @default.
• W2952740406 hasConcept C31896038 @default.
• W2952740406 hasConcept C55493867 @default.
• W2952740406 hasConcept C71240020 @default.
• W2952740406 hasConcept C86803240 @default.

• next